Net profit of Biocon declined 43.72% to Rs 38.10 crore in the quarter ended March 2022 as against Rs 67.70 crore during the previous quarter ended March 2021. Sales rose 5.31% to Rs 517.70 crore in the quarter ended March 2022 as against Rs 491.60 crore during the previous quarter ended March 2021.
For the full year,net profit declined 69.30% to Rs 86.10 crore in the year ended March 2022 as against Rs 280.50 crore during the previous year ended March 2021. Sales declined 14.31% to Rs 1738.20 crore in the year ended March 2022 as against Rs 2028.40 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 517.70 | 491.60 | 5 | 1738.20 | 2028.40 | -14 |
OPM % | 5.12 | 13.61 | – | 3.52 | 15.41 | – |
PBDT | 87.30 | 111.70 | -22 | 247.90 | 462.30 | -46 |
PBT | 59.20 | 86.30 | -31 | 139.70 | 358.80 | -61 |
NP | 38.10 | 67.70 | -44 | 86.10 | 280.50 | -69 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.